Eight million people die of cancer each year and 90% of deaths are caused by systemic
disease. Circulating tumor cells (CTCs) contribute to the formation of metastases and thus …

Simple Summary With estimated numbers of 1–10 per mL of blood, circulating tumor cells
(CTCs) are extremely rare compared to white (a few million) or red (billions) blood cells …

The presence of circulating tumor cells (CTCs) in peripheral blood can serve as a “liquid
biopsy” approach and has thus emerged lately as one of the hottest fields in cancer …

Abstract Detection of Circulating Tumor Cells (CTCs) in peripheral blood can serve as a
“liquid biopsy” approach and as a source of valuable tumor markers. CTCs are rare, and …

Circulating tumor cells (CTCs) are cells derived from the primary sites of tumor patients into
peripheral blood and serve as seeds that initiate tumor metastasis to distant sites. As a …

Hematogeneous tumor cell dissemination is a key step in cancer progression. The detection
of CTCs in the peripheral blood of patients with solid epithelial tumors (eg, breast, prostate …

Circulating tumor cells (CTCs) are cells that shed from a primary tumor and travel through
the bloodstream. Studying the functional and molecular characteristics of CTCs may provide …

The potential clinical utility of circulating tumor cells (CTCs) in the diagnosis and
management of cancer has drawn a lot of attention in the past 10 years. CTCs disseminate …

Disseminated malignancy is responsible for the vast majority of cancer-related deaths.
During this process, circulating tumor cells (CTC) are generated, spread from the primary …

Detection and analysis of circulating tumor cells (CTCs) from patients with metastatic
malignancies have become active areas of research in recent years. CTC enumeration has …